This article was originally published in The Gray Sheet
Executive SummaryMinneapolis-based firm begins shipments of its Model 9790 portable programmer, approved Nov. 18 by FDA via PMA supplement. Medtronic says the 9790 can be used with all Medtronic pacers and defibrillators but is specifically designed for use with the firm's Thera pacemakers and Jewel PCD defibrillators, both of which are still in clinical trials in the U.S. The 18-pound device is more portable than Medtronic's earlier generation 9760 and 9710 devices, the company says. The 9790 carries a list price of $19,000, but many of the systems will be loaned to hospitals using Medtronic pacers and defibrillators
You may also be interested in...
Strategy could improve chances of passage, offer politicians the opportunity to show the public they are doing something to address drug pricing.
House passes Democratic bill authorizing the federal government to negotiate drug prices in Medicare. While the exercise has sharpened the debate over how prices feed innovation, the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Our table highlights the key provisions of HR 3 and other pending pricing legislation.
The new Eudamed database may be delayed for two years, but the European Commission wants to allow early access to Single Registration Numbers before Eudamed goes live in 2022 to aid voluntary registration in the interim.